CD319 (SLAMF7) an alternative marker for detecting plasma cells in the presence of daratumumab or elotuzumab is a research paper published in Cytometry Part B Clinical Cytometry (2020). On theSindex it has a DataRank of 0. It has been cited 45 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: P30 CA016056
National Institutes of Health
National Cancer Institute
Roswell Park Cancer Institute
MeSH Terms
Keywords